CD4 and myeloid sarcoma: Reactivity to guanosine diphosphate (GDP)-L-fucose synthase (GDPLFS) was first identified by systematically screening brain-infiltrating CD4+ T cell clones from MS patients for reactivity to a peptide library (70).